Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults

NCT01575288 is registered in ClinicalTrials.gov with University of Colorado, Boulder as lead sponsor.

NCT NCT01575288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01575288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
Lead sponsor
University of Colorado, Boulder
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2012
Completion date
December 31, 2015
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vascular aging